Episode notes
In this episode of Fort Worth Innovates, host Cameron Cushman sits down with Dr. Chris Naler, COO and Vice President of Growth and EdTech at General Genomics, a Fort Worth–based AI and biotech company transforming healthcare, bioinformatics, and national security through predictive analytics and machine learning. A retired Marine Corps Colonel, Dr. Naler shares how General Genomics is using its proprietary AI platforms to analyze massive healthcare data sets, identify disease risk earlier, and support breakthroughs in areas like Alzheimer’s, dementia, and other neurodegenerative diseases. The conversation explores the difference between AI and machine learning, how predictive models can move healthcare from reactive to proactive, and why Fort Worth is emerging as a major hub for innovation, research, and applied technology. Dr. Naler also discusses the company’s work with government, healthcare, and university partners, as well as its upcoming AI for Executives workshop designed to help leaders better understand and implement AI in their organizations.
Sign up for the AI for Executives workshop on May 29th, 2026: https://airtable.com/appHXOMocrWjKAb5P/pagc9KrNmwuxFWXQL/form
Learn more about General Genomics: https://ggenomics.com/
Learn more about Fort Worth-Tarrant County Innovation Partnership: https://fwtc-innovate.com/